⌘K
Loading ticker…
GLOBUS MEDICAL INC · Healthcare · Medical Equipment
As of 2026-06-26, GLOBUS MEDICAL INC (GMED) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.9%, relative volume 1.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
39 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
GMED is in a stage 3 topping pattern, week 4. Currently in a 47-day base; basing ADR 3.3% (broad 2.9%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 2.8% / 5.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
GMED is held by 12 ETFs as of Mar 2026. Top owner: IJH at 0.30% weight, $318M notional. Top 3 carry $850M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJHiShares Core S&P Mid-Cap ETF | 0.30% | $318M |
| VTIVanguard Total Stock Market ETF | 0.02% | $308M |
| VBVanguard Small Cap ETF | 0.14% | $224M |
| VBKVanguard Small-Cap Growth ETF | 0.32% | $125M |
| VXFVanguard Extended Market ETF | 0.13% | $107M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | 0.30% | $72M |
| IWRiShares Russell Midcap ETF | 0.08% | $37M |
| IWDiShares Russell 1000 Value ETF | 0.03% | $22M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.02% | $12M |
| IUSGiShares Core S&P U.S. Growth ETF | 0.03% | $8M |
Showing 10 of 12 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GMED Jan avg: 4.17% median: 2.76% win: 75% σ: 5.64% n: 4 2022-04-12 → 2026-05-29 | GMED Feb avg: -7.14% median: -5.55% win: 50% σ: 13.22% n: 4 2022-04-12 → 2026-05-29 | GMED Mar avg: -5.54% median: -5.89% win: 0% σ: 4.46% n: 4 2022-04-12 → 2026-05-29 | GMED Apr avg: -2.65% median: -1.95% win: 40% σ: 6.70% n: 5 2022-04-12 → 2026-05-29 | GMED May avg: 0.34% median: -6.90% win: 40% σ: 20.31% n: 5 2022-04-12 → 2026-05-29 | GMED Jun avg: -0.98% median: 0.89% win: 50% σ: 10.76% n: 4 2022-04-12 → 2026-05-29 (current) | GMED Jul avg: 0.00% median: 2.88% win: 75% σ: 7.42% n: 4 2022-04-12 → 2026-05-29 | GMED Aug avg: 2.02% median: 0.94% win: 75% σ: 10.95% n: 4 2022-04-12 → 2026-05-29 | GMED Sep avg: -3.93% median: -4.06% win: 25% σ: 4.15% n: 4 2022-04-12 → 2026-05-29 | GMED Oct avg: 3.19% median: 4.12% win: 75% σ: 8.47% n: 4 2022-04-12 → 2026-05-29 | GMED Nov avg: 18.93% median: 13.35% win: 75% σ: 22.51% n: 4 2022-04-12 → 2026-05-29 | GMED Dec avg: 2.92% median: -1.44% win: 50% σ: 10.67% n: 4 2022-04-12 → 2026-05-29 |